NCT04979871View on ClinicalTrials.gov

SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions
Vaccine Reaction
Interventions
PROCEDURE

Venous bleeding

Blood samples collected 5 times with approx. 2-4 weeks interval

Trial Locations (1)

8091

Univeristy Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT04979871 - SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19 | Biotech Hunter | Biotech Hunter